TerminatedPhase 2NCT02415608
Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jason Robert Gotlib
- Principal Investigator
- Jason Gotlib, M.D., M.SStanford University Hospitals and Clinics
- Intervention
- Ibrutinib(drug)
- Enrollment
- 4 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2017
Study locations (1)
- Stanford University Hospitals and Clinics, Stanford, California, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02415608 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.